
Proximal Ventures Raises $27.5M Fund for AI Drug Development
Proximal Ventures, founded by former SignalFire investor Sahir Raoof, has closed its debut fund at $27.5 million. The firm will back early-stage startups using AI to improve drug discovery, clinical trials, pharmaceutical manufacturing and related services.










